Literature DB >> 2846175

Cytolytic response of human T cells against allogeneic small cell lung carcinoma treated with interferon gamma.

P Weynants1, P Wauters, P G Coulie, B Van den Eynde, M Symann, T Boon.   

Abstract

Human lymphocytes stimulated in vitro by allogeneic small cell lung carcinoma cell lines did not show any significant cytolytic activity against the stimulator tumor cells. However, a high level of lysis was observed when both stimulator and target small cell lung carcinoma cells were pretreated with interferon gamma, which increased considerably the expression of major histocompatibility class I molecules by these cells. The demonstration that small cell lung carcinoma cells can be lysed by cytolytic T lymphocytes, suggests that it will be feasible to study the autologous T cell response of patients against this tumor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846175     DOI: 10.1007/bf00205444

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  21 in total

1.  Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity.

Authors:  S F Slovin; R D Lackman; S Ferrone; P E Kiely; M J Mastrangelo
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

2.  Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions.

Authors:  S C Meuer; S F Schlossman; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

3.  Role of MHC class-I antigens and the CD3 complex in the lysis of autologous human tumours by T-cell clones.

Authors:  T E Roberts; U Shipton; M Moore
Journal:  Int J Cancer       Date:  1987-04-15       Impact factor: 7.396

4.  Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma.

Authors:  A Anichini; G Fossati; G Parmiani
Journal:  Int J Cancer       Date:  1985-05-15       Impact factor: 7.396

5.  Production of stable cytolytic T-cell clones directed against autologous human melanoma.

Authors:  M Hérin; C Lemoine; P Weynants; F Vessière; A Van Pel; A Knuth; R Devos; T Boon
Journal:  Int J Cancer       Date:  1987-03-15       Impact factor: 7.396

6.  Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation.

Authors:  K Hui; F Grosveld; H Festenstein
Journal:  Nature       Date:  1984 Oct 25-31       Impact factor: 49.962

7.  Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.

Authors:  S Carrel; A Schmidt-Kessen; L Giuffrè
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

8.  Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.

Authors:  A Doyle; W J Martin; K Funa; A Gazdar; D Carney; S E Martin; I Linnoila; F Cuttitta; J Mulshine; P Bunn
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

9.  Monoclonal cytolytic T-cell lines.

Authors:  P E Baker; S Gillis; K A Smith
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

10.  Clonal analysis of cytotoxic T cell response against human melanoma.

Authors:  B Mukherji; T J MacAlister
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

View more
  3 in total

1.  Differential growth inhibition and enhancement of major histocompatibility complex class I antigen expression by interferons in a small-cell lung cancer cell line and its doxorubicin-selected multidrug-resistant variant.

Authors:  S P Cole; B M Campigotto; J G Johnson; B E Elliott
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Killer cells induced by stimulation with allogeneic tumor cells and subsequent culture with recombinant interleukin-2.

Authors:  T Fukiage; H Murakami; M Eura; T Ikawa; T Ishikawa
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Shorter telomere length of T-cells in peripheral blood of patients with lung cancer.

Authors:  Yaqin Qian; Tingting Ding; Lijuan Wei; Shui Cao; Lili Yang
Journal:  Onco Targets Ther       Date:  2016-05-04       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.